Tokyo, Japan

Tatsuhiko Kodoma

This inventor holds 1 USPTO granted patent. Top assignee: Kowa Company Limited. Active years: 2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tatsuhiko Kodoma. Retrieved from https://idiyas.com/inventor/tatsuhiko-kodoma

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 15(Granted Patents)


Company Filing History:


Years Active: 2002

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Tatsuhiko Kodoma: A Profile of an Inventor in Tokyo

Introduction: Tatsuhiko Kodoma is an accomplished inventor based in Tokyo, Japan. Known for his contributions in the field of pharmaceuticals, he has made a significant impact with his innovative ideas. His work reflects a commitment to advancing science and improving health outcomes through inventive solutions.

Latest Patents: Tatsuhiko Kodoma holds one notable patent for a piperazine derivative. This compound is pivotal in the development of various pharmaceutical applications, showcasing his ability to innovate in a complex and competitive industry.

Career Highlights: As a vital member of Kowa Company Limited, Tatsuhiko Kodoma has played an integral role in the company's research and development initiatives. His dedication to innovation and his expertise in pharmaceutical sciences have positioned him as a key figure within the organization.

Collaborations: Throughout his career, Tatsuhiko has collaborated with other esteemed professionals, including Masahiro Tamura and Toshiaki Oda. These partnerships have likely fostered a rich environment for creative ideas and technological advancements within the organization.

Conclusion: Tatsuhiko Kodoma's contributions to the field of invention and innovation illustrate the importance of teamwork and dedication in the pursuit of scientific advancement. His accomplishments at Kowa Company Limited demonstrate not only his personal commitment to innovation but also the collaborative spirit that drives progress in the pharmaceutical industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…